Hodgkin's lymphoma in developing countries: can we go further?
作者信息
Gaiolla Rafael Dezen
机构信息
Universidade Estadual "Júlio de Mesquita Filho" (UNESP), Botucatu, SP, Brazil.
出版信息
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):299-300. doi: 10.1016/j.bjhh.2017.08.004. Epub 2017 Oct 13.
Abstract
摘要
相似文献
1
Hodgkin's lymphoma in developing countries: can we go further?发展中国家的霍奇金淋巴瘤：我们能否更进一步？
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):299-300. doi: 10.1016/j.bjhh.2017.08.004. Epub 2017 Oct 13.
2
AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.巴西的艾滋病相关淋巴瘤。组织病理学、免疫表型及与爱泼斯坦-巴尔病毒的关联
Am J Clin Pathol. 1996 Feb;105(2):230-7. doi: 10.1093/ajcp/105.2.230.
3
Cutaneous Melanoma, Hodgkin's Lymphoma and non-Hodgkin's Lymphoma: Common Risk Factors?皮肤黑色素瘤、霍奇金淋巴瘤和非霍奇金淋巴瘤：共同的危险因素？
Cent Eur J Public Health. 2015 Jun;23(2):119-21. doi: 10.21101/cejph.a4090.
4
Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.靶向细胞FLICE样抑制蛋白作为治疗霍奇金淋巴瘤的新方法。
Expert Rev Anticancer Ther. 2006 Jun;6(6):911-9. doi: 10.1586/14737140.6.6.911.
5
Non-Hodgkin's lymphoma of the thyroid gland occurring after treated Hodgkin's lymphoma.经治疗的霍奇金淋巴瘤后发生的甲状腺非霍奇金淋巴瘤。
Endocr Pract. 1997 Sep-Oct;3(5):302-4. doi: 10.4158/EP.3.5.302.
6
The pattern of haematological and lymphoreticular malignancy in Zimbabwe.津巴布韦血液学和淋巴网状系统恶性肿瘤的模式。
Trop Geogr Med. 1988 Apr;40(2):109-14.
7
Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient.一名感染HIV的患者在霍奇金病长期缓解后发生非霍奇金淋巴瘤。
Ann Oncol. 1991 Sep;2(8):585-7. doi: 10.1093/oxfordjournals.annonc.a058025.
8
High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.霍奇金淋巴瘤的原发性难治性疾病发生率高且无进展生存率低：拉丁美洲一个中心的十年经验
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):325-330. doi: 10.1016/j.bjhh.2017.08.001. Epub 2017 Sep 14.
9
Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.中国霍奇金淋巴瘤患者的临床特征和预后因素。
Med Oncol. 2012 Jun;29(2):1127-33. doi: 10.1007/s12032-011-9902-3. Epub 2011 Mar 10.
10
Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.霍奇金病治疗后非霍奇金淋巴瘤的发生
N Engl J Med. 1979 Mar 1;300(9):452-8. doi: 10.1056/NEJM197903013000902.
引用本文的文献
1
Subgroup analysis of treatment pathways and clinical outcomes in Hodgkin lymphoma in Latin America from the retrospective B-HOLISTIC study.拉丁美洲霍奇金淋巴瘤治疗途径和临床结局的亚组分析：回顾性B-HOLISTIC研究
Sci Rep. 2025 Jul 7;15(1):24197. doi: 10.1038/s41598-025-07704-0.
本文引用的文献
1
High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.霍奇金淋巴瘤的原发性难治性疾病发生率高且无进展生存率低：拉丁美洲一个中心的十年经验
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):325-330. doi: 10.1016/j.bjhh.2017.08.001. Epub 2017 Sep 14.
2
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.较低的社会经济地位与霍奇金淋巴瘤患者的生存时间缩短独立相关-来自巴西霍奇金淋巴瘤登记处的分析。
Int J Cancer. 2018 Mar 1;142(5):883-890. doi: 10.1002/ijc.31096. Epub 2017 Oct 26.
3
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.霍奇金淋巴瘤的治疗结果：巴西前瞻性登记处的首份报告。
Hematol Oncol. 2018 Feb;36(1):189-195. doi: 10.1002/hon.2450. Epub 2017 Jun 23.
4
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者，比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
5
Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia.霍奇金淋巴瘤结局：来自沙特阿拉伯 3 家三级中心的回顾性研究。
Oncol Res Treat. 2017;40(5):288-292. doi: 10.1159/000460819. Epub 2017 Apr 7.
6
Response Assessment Criteria and Their Applications in Lymphoma: Part 2.淋巴瘤的疗效评估标准及其应用：第2部分。
J Nucl Med. 2017 Jan;58(1):13-22. doi: 10.2967/jnumed.116.184242. Epub 2016 Nov 22.
7
Treatment of advanced-stage Hodgkin lymphoma.晚期霍奇金淋巴瘤的治疗
Semin Hematol. 2016 Jul;53(3):171-9. doi: 10.1053/j.seminhematol.2016.05.006. Epub 2016 May 12.
8
Clinical profile and outcome of adult Hodgkin lymphoma: Experience from a tertiary care institution.成人霍奇金淋巴瘤的临床特征与转归：来自一家三级医疗机构的经验
Indian J Med Paediatr Oncol. 2015 Oct-Dec;36(4):255-60. doi: 10.4103/0971-5851.171550.
9
A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: the role of ABVD in daily practice.一项针对314例新诊断的晚期霍奇金淋巴瘤患者的单机构经验：ABVD方案在日常实践中的作用。
Eur J Haematol. 2014 Nov;93(5):392-9. doi: 10.1111/ejh.12364. Epub 2014 May 26.
10
Hodgkin's lymphoma mortality in the Americas, 1997-2008: achievements and persistent inadequacies.1997-2008 年美洲霍奇金淋巴瘤死亡率：成就与持续不足。
Int J Cancer. 2013 Aug 1;133(3):687-94. doi: 10.1002/ijc.28049. Epub 2013 Feb 25.
Zotero 插件